RxDoctor Payments Data

Mia Mong, PA

Physician Assistant · Erie, PANPI 1053888339

Payments from drug & device makers

$5,338in general payments, 2019–2025

Across 126 payments — averaging $42.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Recor Medical Inc$563
  • Amgen$279
  • Boehringer Ingelheim$236
  • E.r. Squibb & Sons, L.L.C.$225
  • Abiomed$217
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$3507%
  • Travel & lodging$1,23123%
  • Food & beverage$3,75770%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,338 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$11,388
Medicare patients
104
Services billed
151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan51$49,281
EliquisApixaban38$26,731
XareltoRivaroxaban16$18,499
Metoprolol Succinate82$963
Ranolazine ErRanolazine16$662
Diltiazem 24hr Er (Cd)Diltiazem Hcl25$491
Bumetanide18$434
Amiodarone Hcl45$431
ClopidogrelClopidogrel Bisulfate93$240
Furosemide85$176
Potassium Chloride24$173
Carvedilol72$166
Cartia XtDiltiazem Hcl11$134
Pantoprazole Sodium30$134
Hydralazine Hcl22$132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$125$49,28151 claims
PfizerEliquis$105$26,73138 claims
Johnson & JohnsonXarelto$213$18,49916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Erie

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →